Global TALZENNA HCP Strategy Lead (Secondment - 6 Months)

Pfizer•New York City, NY

1d•Hybrid

About The Position

Pfizer Commercial Oncology is entering a new era of cancer care with a growing portfolio of novel therapies and a goal of delivering eight breakthroughs by 2030. The TALZENNA Global Marketing Team is preparing for the launch of TALAPRO-3, the second and final prostate cancer indication for the brand. This role is a 6-month secondment to drive integrated HCP launch strategies to completion and ensure a seamless handoff to markets. The TALZENNA brand is a key part of Pfizer's commitment to bringing clinically meaningful new therapies to mPC patients, offering oral treatment options to deepen and prolong responses in mPC.

Requirements

Bachelor's degree with at least 8+ years of experience.
Able to collaborate across different functions and interact with others in a way that gains commitment to action, ensures clarity, and creates common goals.
Strong written, oral communication skills coupled with strong analytical skills; able to distill complex data into compelling communications.
Mature, self-starter, detail-oriented, action-driven, comfortable with ambiguity; able to multi-task in dynamic environment.
Team player who is patient-focused and focused on Pfizer values: Courage, Excellence, Equity, and Joy by fostering innovation, customer focus, personal accountability, and a commitment for results.
Demonstrated track record of conducting activities in accordance with company policies and SOPs, Pfizer values and regulatory guidelines.
Permanent work authorization in the United States.

Nice To Haves

Master's degree with at least 7+ years of experience; OR a PhD with 5+ years of experience, OR a MD with 4+ years of experience.

Responsibilities

Lead TALAPRO-3 HCP strategy and promotional materials.
Lead OS scenario planning for TALAPRO-3.
Lead TALAPRO-2 Global strategy and communication, refining strategy & tactics in response to competitive landscape.
Lead CoLab interactions, including project plan review & management of CoLab OpEx.
Rollout Updated HCP segments and finalize HCP Narrative by Segment.
Lead Global KOL engagement strategy including Commercial Advisory Board Meetings and Peer Exchange Programs.
Provide support and oversight to the TALZENNA Marketing Rotational Colleague (MRP) who will be finalizing and executing on some other key HCP materials.
Finalization and rollout of branded campaign materials including promotional campaign video.
Finalization of TP2 and TP3 Objection Handler.
Development of TP3 CCP Guidance Document and DSP.
Execution of the updated patient profiles.